Escuela de Medicina y Ciencias de la Salud. Tecnológico de Monterrey. Monterrey. México   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Monterrey Mexico (1978)

Organization Overview

First Clinical Trial
2008
NCT03432663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Escuela de Medicina y Ciencias de la Salud. Tecnológico de Monterrey. Monterrey. México | Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud

Active Ingredients

Drugs in Phase 4 Trials (1)

amiodarone (cordarone) (1 trial)

Drugs in Phase 2 Trials (1)

rituximab (rituxan) (1 trial)

Drugs in Phase 1 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3